Clinical implementation of an uveitis prediction model

Completed

• Conditions: Uveitis; 10021877

• Registration Number: NL-OMON46803
• Lead Sponsor: Oogziekenhuis Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 250

Inclusion Criteria

- Non-infectious uveitis.
- Age >= 18 years.
- Informed consent.

Exclusion Criteria

- Major eye condition preventing any VA improvement or reduction (such as end stage glaucoma, end stage corneal diseases, end stage macular degeneration).
- Suspected or proven infectious uveitis.
- Masquerade syndromes (such as intraocular B cell lymphoma).
- Patients for whom all data of the first year since onset of their uveitis are missing.
- Patients for whom, since onset of their uveitis, data (> 3 years) are missing.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Best corrected visual acuity.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Duration and dose immunosuppressives.<br /><br>See Ch. 8 of the protocol.</p><br>